173 related articles for article (PubMed ID: 23928945)
1. Scleral fixation of dexamethasone intravitreal implant (OZURDEX®) in a case of angle-supported lens implantation.
Mateo C; Alkabes M; Burés-Jelstrup A
Int Ophthalmol; 2014 Jun; 34(3):661-5. PubMed ID: 23928945
[TBL] [Abstract][Full Text] [Related]
2. Management of anterior chamber dislocation of a dexamethasone intravitreal implant: a case report.
Pacella F; Agostinelli E; Carlesimo SC; Nebbioso M; Secondi R; Forastiere M; Pacella E
J Med Case Rep; 2016 Oct; 10(1):282. PubMed ID: 27733187
[TBL] [Abstract][Full Text] [Related]
3. The clinical outcomes of surgical management of anterior chamber migration of a dexamethasone implant (Ozurdex®).
Kang H; Lee MW; Byeon SH; Koh HJ; Lee SC; Kim M
Graefes Arch Clin Exp Ophthalmol; 2017 Sep; 255(9):1819-1825. PubMed ID: 28601910
[TBL] [Abstract][Full Text] [Related]
4. Anterior Chamber Migration of Ozurdex Implants.
Kayıkcıoğlu Ö; Doğruya S; Sarıgül C; Mayalı H; Kurt E
Turk J Ophthalmol; 2020 Apr; 50(2):115-122. PubMed ID: 32367704
[TBL] [Abstract][Full Text] [Related]
5. Repositioning of dexamethasone intravitreal implant (Ozurdex) migrated into the anterior chamber.
Vela JI; Crespí J; Andreu D
Int Ophthalmol; 2012 Dec; 32(6):583-4. PubMed ID: 22763812
[TBL] [Abstract][Full Text] [Related]
6. [Anterior chamber migration of a dexamethasone implant in a pseudophakic patient with a scleral-fixated posterior chamber intraocular lens].
Laplace O; Rodallec T; Akesbi J; Sandali O
J Fr Ophtalmol; 2013 Apr; 36(4):e59-61. PubMed ID: 23433821
[TBL] [Abstract][Full Text] [Related]
7. Surgical Management of Anterior Chamber Migration of a Dexamethasone Intravitreal Implant.
Stelton CR; Townsend J; Peterson LT; Khurana RN; Yeh S
Ophthalmic Surg Lasers Imaging Retina; 2015; 46(7):756-9. PubMed ID: 26247457
[TBL] [Abstract][Full Text] [Related]
8. Anterior Chamber Dislocation of Dexamethasone Implant in the Presence of Carlevale Sutureless Scleral Fixation Intraocular Lens.
Stavrakas P; Gartaganis P; Totou S; Chalkiadaki E; Manousakis E; Karmiris E
Case Rep Ophthalmol; 2023; 14(1):229-233. PubMed ID: 37383169
[TBL] [Abstract][Full Text] [Related]
9. Dexamethasone implant anterior chamber migration: risk factors, complications, and management strategies.
Khurana RN; Appa SN; McCannel CA; Elman MJ; Wittenberg SE; Parks DJ; Ahmad S; Yeh S
Ophthalmology; 2014 Jan; 121(1):67-71. PubMed ID: 23890421
[TBL] [Abstract][Full Text] [Related]
10. Anterior chamber migration of dexamethasone intravitreal implant (Ozurdex®) through basal iridectomy (Ando) in a pseudophakic patient.
Stepanov A; Codenotti M; Ramoni A; Prati M; Jiraskova N; Rozsival P; Bandello F
Eur J Ophthalmol; 2016 Apr; 26(3):e52-4. PubMed ID: 26615950
[TBL] [Abstract][Full Text] [Related]
11. Spontaneous extrusion of a dexamethasone intravitreal implant (Ozurdex).
Ong J; Davidoss NH; Bhosale A; Balaratnasingam C
BMJ Case Rep; 2020 Nov; 13(11):. PubMed ID: 33148568
[TBL] [Abstract][Full Text] [Related]
12. Intracrystalline Ozurdex
Clemente-Tomás R; Hernández-Pérez D; Neira-Ibáñez P; Farías-Rozas F; Torrecillas-Picazo R; Osorio-Alayo V; Duch-Samper AM
Int Ophthalmol; 2019 Jan; 39(1):207-211. PubMed ID: 29192395
[TBL] [Abstract][Full Text] [Related]
13. [Tolerability and short-term efficacy of the Ozurdex® dexamethasone intravitreal implant for treatment of uveitic cystoid macular edema: A retrospective study of 52 injections performed at the Clermont-Ferrand teaching hospital].
Bernard Y; Bonnin N; Farguette F; Chiambaretta F
J Fr Ophtalmol; 2016 Jan; 39(1):1-4. PubMed ID: 26616298
[TBL] [Abstract][Full Text] [Related]
14. Intravitreal Dexamethasone Implant for the Treatment of Postoperative Macular Edema.
Klamann A; Böttcher K; Ackermann P; Geerling G; Schargus M; Guthoff R
Ophthalmologica; 2016; 236(4):181-185. PubMed ID: 27915343
[TBL] [Abstract][Full Text] [Related]
15. [A cost-effectiveness study of dexamethasone implants in macular edema].
Lozano López V; Serrano García M; Mantolán Sarmiento C; Pareja Ríos A; Losada Castillo MJ; Cordovés Dorta L; Quijada Fumero E; Virgós Aller T; Bullejos Molina M
Arch Soc Esp Oftalmol; 2015 Jan; 90(1):14-21. PubMed ID: 25443181
[TBL] [Abstract][Full Text] [Related]
16. Incomplete scleral penetration of dexamethasone (Ozurdex) intravitreal implant.
Sherman T; Raman V
BMJ Case Rep; 2018 Dec; 11(1):. PubMed ID: 30567246
[TBL] [Abstract][Full Text] [Related]
17. [Reliability and safety of intravitreal Ozurdex injections. The ZERO study].
Schmitz K; Maier M; Clemens CR; Höhn F; Wachtlin J; Lehmann F; Bertelmann T; Rüdiger K; Horn M; Bezatis A; Spital G; Meyer CH;
Ophthalmologe; 2014 Jan; 111(1):44-52. PubMed ID: 23559321
[TBL] [Abstract][Full Text] [Related]
18. The Use of Ozurdex (Dexamethasone Intravitreal Implant) During Anterior Segment Surgery in Patients with Chronic Recurrent Uveitis.
Ragam AP; Kolomeyer AM; Nayak NV; Chu DS
J Ocul Pharmacol Ther; 2015; 31(6):344-9. PubMed ID: 26061893
[TBL] [Abstract][Full Text] [Related]
19. Dexamethasone intravitreal implant for treatment of uveitic persistent cystoid macular edema in vitrectomized patients.
Adán A; Pelegrín L; Rey A; Llorenç V; Mesquida M; Molins B; Ríos J; Keller J
Retina; 2013; 33(7):1435-40. PubMed ID: 23514796
[TBL] [Abstract][Full Text] [Related]
20. Inadvertent dexamethasone implant injection into the lens body management.
Berarducci A; Sian IS; Ling R
Eur J Ophthalmol; 2014; 24(4):620-2. PubMed ID: 24519508
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]